Skeletal effects of estrogen analogs
- 1 January 1997
- journal article
- review article
- Published by Springer Nature in Osteoporosis International
- Vol. 7 (S1), 40-42
- https://doi.org/10.1007/bf01674812
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal womenJournal of Bone and Mineral Research, 1996
- The menopause and osteoporosisObstetrics & Gynecology, 1996
- Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal womenBone and Mineral, 1993
- Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosisJournal of Bone and Mineral Research, 1993
- Effect of long term tamoxifen treatment on bone turnover in women with breast cancer.BMJ, 1993
- Tamoxifen protects against steroid-induced bone lossEuropean Journal Of Cancer, 1992
- Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast CancerNew England Journal of Medicine, 1992
- Effects of Tamoxifen on Spinal Bone Density in Women With Breast CancerJNCI Journal of the National Cancer Institute, 1989
- Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two yearsBreast Cancer Research and Treatment, 1988
- Organon OD 14 (Tibolone) and menopausal dynamic hormone profilesMaturitas, 1986